Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 98422T100 since 12/18/2024, largest first.
| Filer | % of Class | Filed | ||
|---|---|---|---|---|
| Gilead Sciences, Inc. 13G/A | 19.9% |
2/12/2026
Event 12/31/2025
|
||
|
Coastlands Capital LP
13G
|
10.0% |
12/11/2025
Event 12/4/2025
|
||
| Coastlands Capital LP | 10.0% | |||
| Coastlands Capital Partners LP | 10.0% | |||
| Coastlands Capital GP LLC | 10.0% | |||
| Coastlands Capital LLC | 10.0% | |||
| Matthew D. Perry | 10.0% | |||
|
Sirenia Capital Management LP
13G
|
9.9% |
5/15/2026
Event 3/31/2026
|
||
| Sirenia Capital Management LP | 9.9% | |||
| Alex Silverstein | 9.9% | |||
| AbbVie Inc. 13G | 9.0% |
2/18/2025
Event 2/11/2025
|
||
|
Bain Capital Life Sciences Fund II, L.P.
13G/A
|
8.5% |
2/17/2026
Event 12/31/2025
|
||
| Bain Capital Life Sciences Fund II, L.P. | 1.3% | |||
| BCIP Life Sciences Associates, LP | 0.2% | |||
| BCLS II Equity Opportunities, LP | 8.5% | |||
| BCLS II Investco, LP | 0% | |||
|
StemPoint Capital LP
13G/A
|
8.4% |
2/17/2026
Event 12/31/2025
|
||
| StemPoint Capital LP | 8.4% | |||
| StemPoint Capital Management GP LLC | 8.4% | |||
| Michelle Ross | 8.4% | |||
|
Frazier Life Sciences Public Fund, L.P.
13G/A
|
6.7% |
2/13/2026
Event 12/31/2025
|
||
| Frazier Life Sciences Public Fund, L.P. | 6.7% | |||
| FHMLSP, L.P. | 6.7% | |||
| FHMLSP, L.L.C. | 6.7% | |||
| Frazier Life Sciences X, L.P. | 0.2% | |||
| FHMLS X, L.P. | 0.2% | |||
| FHMLS X, L.L.C. | 0.2% | |||
| Frazier Life Sciences XI, L.P. | 0.6% | |||
| FHMLS XI, L.P. | 0.6% | |||
| FHMLS XI, L.L.C. | 0.6% | |||
| Frazier Life Sciences XII, L.P. | 1.0% | |||
| FHMLS XII, L.P. | 1.0% | |||
| FHMLS XII, L.L.C. | 1.0% | |||
| James N. Topper | 0.2% | |||
| Patrick J. Heron | 0.2% | |||
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (2) | ||||
|
Point72 Asset Management, L.P.
13G/A
|
0% |
5/15/2026
Event 3/31/2026
|
||
| Point72 Asset Management, L.P. | 0% | |||
| Point72 Capital Advisors, Inc. | 0% | |||
| Steven A. Cohen | 0% | |||
|
Rock Springs Capital Management LP
13G/A
|
0% |
5/15/2025
Event 3/31/2025
|
||
| Rock Springs Capital Management LP | 0% | |||
| Rock Springs Capital LLC | 0% | |||
| Rock Springs Capital Master Fund LP | 0% | |||
| Mark Bussard | 0% | |||
| Kris Jenner | 0% | |||
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q2 | 1 | 650 k | $6.23 M |
| 2026 Q1 | 1 | 650 k | $5.47 M |
| 2025 Q4 | 37 | 39.7 M | $25.4 M |
| 2025 Q3 | 36 | 22.1 M | $18.6 M |
| 2025 Q2 | 36 | 23.8 M | $16.2 M |
| 2025 Q1 | 36 | 22.5 M | $16.3 M |
| 2024 Q4 | 36 | 25.9 M | $24.7 M |
| 2024 Q3 | 35 | 16.0 M | $12.6 M |
| 2024 Q2 | 35 | 15.6 M | $14.8 M |
| 2024 Q1 | 35 | 12.9 M | $14.0 M |
| 2023 Q4 | 37 | 16.6 M | $9.11 M |
| 2023 Q3 | 32 | 15.9 M | $33.5 M |
| 2023 Q2 | 33 | 16.0 M | $41.9 M |
| 2023 Q1 | 33 | 16.1 M | $51.0 M |
| 2022 Q4 | 30 | 15.9 M | $42.9 M |
| 2022 Q3 | 30 | 16.6 M | $48.3 M |
| 2022 Q2 | 34 | 17.9 M | $52.2 M |
| 2022 Q1 | 42 | 18.8 M | $133 M |
| 2021 Q4 | 43 | 19.0 M | $303 M |